NO163957C - Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.Info
- Publication number
- NO163957C NO163957C NO855241A NO855241A NO163957C NO 163957 C NO163957 C NO 163957C NO 855241 A NO855241 A NO 855241A NO 855241 A NO855241 A NO 855241A NO 163957 C NO163957 C NO 163957C
- Authority
- NO
- Norway
- Prior art keywords
- sup
- carbapnam
- relations
- preparation
- therapeutically active
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 231100000417 nephrotoxicity Toxicity 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
- Steroid Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28170084 | 1984-12-25 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO855241L NO855241L (no) | 1986-06-26 |
| NO163957B NO163957B (no) | 1990-05-07 |
| NO163957C true NO163957C (no) | 1990-08-15 |
Family
ID=17642759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO855241A NO163957C (no) | 1984-12-25 | 1985-12-23 | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4740507A (xx) |
| EP (1) | EP0186525B1 (xx) |
| JP (1) | JPS61275279A (xx) |
| KR (1) | KR930005332B1 (xx) |
| CN (1) | CN1014246B (xx) |
| AT (1) | ATE51624T1 (xx) |
| AU (1) | AU575232B2 (xx) |
| CA (1) | CA1254562A (xx) |
| DE (1) | DE3576957D1 (xx) |
| DK (1) | DK169384B1 (xx) |
| ES (2) | ES8706148A1 (xx) |
| FI (1) | FI81576C (xx) |
| HU (1) | HU196071B (xx) |
| IE (1) | IE58823B1 (xx) |
| NO (1) | NO163957C (xx) |
| NZ (1) | NZ214676A (xx) |
| PH (1) | PH25391A (xx) |
| ZA (1) | ZA859797B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60202886A (ja) * | 1984-03-27 | 1985-10-14 | Sankyo Co Ltd | １―置換カルバペネム―３―カルボン酸誘導体 |
| JPS6426580A (en) * | 1987-07-21 | 1989-01-27 | Sankyo Co | Production of carbapenem derivative |
| US5102877A (en) * | 1989-04-28 | 1992-04-07 | Fujisawa Pharmaceutical Co., Ltd. | 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
| US5286721A (en) * | 1990-10-15 | 1994-02-15 | Fujisawa Pharmaceutical Co., Ltd. | 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds |
| TW209220B (xx) * | 1991-11-27 | 1993-07-11 | Manyu Seiyaku Kk | |
| GB9202298D0 (en) * | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| GB9210096D0 (en) * | 1992-05-11 | 1992-06-24 | Fujisawa Pharmaceutical Co | 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation |
| JP2696807B2 (ja) * | 1992-08-06 | 1998-01-14 | 田辺製薬株式会社 | カルバペネム誘導体の製法 |
| SK108099A3 (en) * | 1997-02-07 | 2000-03-13 | Kyoto Pharmaceutical Ind | Carbapenem compounds, use thereof, and intermediate compounds of the same |
| BR9910098A (pt) | 1998-05-01 | 2000-12-26 | Kyoto Pharma Ind | Derivados de carbapenem, utilização dos mesmos e compostos intermediários dos mesmos |
| NZ530170A (en) * | 2001-05-21 | 2005-09-30 | Kyoto Pharma Ind | Carbapenem compound |
| GB0400382D0 (en) * | 2004-01-09 | 2004-02-11 | Glaxo Group Ltd | Novel processes |
| US7932381B2 (en) * | 2005-02-15 | 2011-04-26 | Shionogi & Co., Ltd. | Process for producing carbapenem derivative and intermediate crystal therefor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4383946A (en) * | 1980-03-27 | 1983-05-17 | Merck & Co., Inc. | Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals |
| US4552873A (en) * | 1981-08-19 | 1985-11-12 | Sankyo Company Limited | Carbapenem compounds, and compositions containing them |
| JPS5913757A (ja) * | 1982-07-14 | 1984-01-24 | Sankyo Co Ltd | ３−メルカプトピロリジン誘導体及びその製法 |
| JPS5916892A (ja) * | 1982-07-19 | 1984-01-28 | Sankyo Co Ltd | カルバペネム−３−カルボン酸誘導体およびその製法 |
| JPS59205379A (ja) * | 1983-05-09 | 1984-11-20 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物及びその製造法 |
| CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
-
1985
- 1985-12-20 JP JP60285663A patent/JPS61275279A/ja active Pending
- 1985-12-20 FI FI855128A patent/FI81576C/fi not_active IP Right Cessation
- 1985-12-23 CN CN85109699A patent/CN1014246B/zh not_active Expired
- 1985-12-23 NO NO855241A patent/NO163957C/no unknown
- 1985-12-23 NZ NZ214676A patent/NZ214676A/xx unknown
- 1985-12-23 IE IE330085A patent/IE58823B1/en not_active IP Right Cessation
- 1985-12-23 US US06/812,344 patent/US4740507A/en not_active Expired - Fee Related
- 1985-12-23 HU HU854957A patent/HU196071B/hu not_active IP Right Cessation
- 1985-12-23 DK DK604485A patent/DK169384B1/da active
- 1985-12-23 ZA ZA859797A patent/ZA859797B/xx unknown
- 1985-12-24 ES ES550403A patent/ES8706148A1/es not_active Expired
- 1985-12-24 PH PH33239A patent/PH25391A/en unknown
- 1985-12-24 AU AU51699/85A patent/AU575232B2/en not_active Ceased
- 1985-12-24 KR KR1019850009792A patent/KR930005332B1/ko not_active IP Right Cessation
- 1985-12-24 CA CA000498605A patent/CA1254562A/en not_active Expired
- 1985-12-30 AT AT85309537T patent/ATE51624T1/de not_active IP Right Cessation
- 1985-12-30 DE DE8585309537T patent/DE3576957D1/de not_active Expired - Fee Related
- 1985-12-30 EP EP85309537A patent/EP0186525B1/en not_active Expired - Lifetime
-
1986
- 1986-08-22 ES ES557035A patent/ES8707535A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU575232B2 (en) | 1988-07-21 |
| IE58823B1 (en) | 1993-11-17 |
| DK604485A (da) | 1986-06-26 |
| DK604485D0 (da) | 1985-12-23 |
| ES557035A0 (es) | 1987-08-01 |
| CN1014246B (zh) | 1991-10-09 |
| EP0186525B1 (en) | 1990-04-04 |
| NO163957B (no) | 1990-05-07 |
| IE853300L (en) | 1986-06-25 |
| KR860004892A (ko) | 1986-07-14 |
| US4740507A (en) | 1988-04-26 |
| FI855128A (fi) | 1986-06-26 |
| HUT39182A (en) | 1986-08-28 |
| FI855128A0 (fi) | 1985-12-20 |
| ES8706148A1 (es) | 1987-06-01 |
| KR930005332B1 (ko) | 1993-06-17 |
| NO855241L (no) | 1986-06-26 |
| HU196071B (en) | 1988-09-28 |
| ES8707535A1 (es) | 1987-08-01 |
| ZA859797B (en) | 1986-09-24 |
| DE3576957D1 (de) | 1990-05-10 |
| FI81576C (fi) | 1990-11-12 |
| PH25391A (en) | 1991-06-03 |
| CN85109699A (zh) | 1986-08-13 |
| ATE51624T1 (de) | 1990-04-15 |
| NZ214676A (en) | 1988-06-30 |
| JPS61275279A (ja) | 1986-12-05 |
| DK169384B1 (da) | 1994-10-17 |
| EP0186525A1 (en) | 1986-07-02 |
| CA1254562A (en) | 1989-05-23 |
| AU5169985A (en) | 1986-07-03 |
| ES550403A0 (es) | 1987-06-01 |
| FI81576B (fi) | 1990-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO164980C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemderivater. | |
| EP0219876A3 (en) | Antihypertensive agents comprising 2-alkynyladenosines as active ingredients | |
| DK291685A (da) | Topisk behandling og praeparat | |
| AU565898B2 (en) | 1,8-naphthyridine derivatives | |
| ES8700672A1 (es) | Un procedimiento para la preparacion de derivados de amino alquilentio-alquilentiofosfonatos. | |
| AU528275B2 (en) | Imidazole derivatives | |
| NO163957C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser. | |
| EP0178189A3 (en) | Pyridazinone derivatives, their preparation and use | |
| YU30292A (sh) | Nova aktivna jedinejnja | |
| AU572978B2 (en) | 1,5-benzothiazepine derivatives | |
| ES8609272A1 (es) | Un procedimiento para preparar derivados de hidantoina | |
| DE3477488D1 (en) | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
| IE792329L (en) | Thiazaheterocyclics and process for preparing pyrrolidine¹and piperidine derivatives. | |
| ES8607963A1 (es) | "un procedimiento para la preparacion de derivados de imi- dazol triciclicos" | |
| IE811212L (en) | Substituted phenoxy-aminopropanol derivatives | |
| EP0151094A3 (en) | Pharmacologically active imidazopyridine compounds | |
| ES8403102A1 (es) | Un procedimiento para la preparacion de esteres fluorofenoxibencilicos. | |
| WO1989011472A1 (en) | Substituted phenylalkylformamines and fungicidal preparation based thereon | |
| ES8400443A1 (es) | Mejoras introducidas en un procedimiento para la preparacion de hidroximidatos y tiolhidroximidatos heterobiciclicos y derivados ester carbamato de lso mismos. |